<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40657777</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">0327-6139</ISSN><JournalIssue CitedMedium="Print"><Volume>36</Volume><Issue>168, abr.- jun.</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>10</Day></PubDate></JournalIssue><Title>Vertex (Buenos Aires, Argentina)</Title><ISOAbbreviation>Vertex</ISOAbbreviation></Journal><ArticleTitle>[Not Available].</ArticleTitle><Pagination><StartPage>39</StartPage><EndPage>44</EndPage><MedlinePgn>39-44</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.53680/vertex.v36i168.833</ELocationID><Abstract><AbstractText>Introducci&#xf3;n: la categor&#xed;a de los Trastornos neurocognitivos (TNC), tambi&#xe9;n llamados Demencias, incluye a aquellos trastornos en los que el d&#xe9;ficit cl&#xed;nico principal es la falla en una o m&#xe1;s funciones cognitivas y que son adquiridos. La Demencia de Inicio Temprano (DIT) se define como un TNC mayor que comienza antes de los 65 a&#xf1;os, con diversas causas etiol&#xf3;gicas y un impacto significativo en los costos de salud y calidad de vida familiar. Los s&#xed;ntomas neuropsiqui&#xe1;tricos, como la depresi&#xf3;n y la ansiedad, pueden ser causas no neurodegenerativas de deterioro y quejas cognitivas. Este estudio se enfoca en describir el rendimiento en la Evaluaci&#xf3;n Neurocognitiva (ENC) y la presencia de depresi&#xf3;n, ansiedad, y otros s&#xed;ntomas neuropsiqui&#xe1;tricos en j&#xf3;venes que consultan por quejas cognitivas en un servicio de neurolog&#xed;a. Materiales y m&#xe9;todos: estudio descriptivo, retrospectivo basado en informes de ENC de pacientes j&#xf3;venes (&#x2264;64 a&#xf1;os) que consultaron por quejas cognitivas entre junio de 2018 y diciembre de 2022. Se excluyeron pacientes con antecedentes de trastornos del neurodesarrollo. Los informes clasificaron a los pacientes en categor&#xed;as basadas en su rendimiento cognitivo y la afectaci&#xf3;n en actividades de la vida diaria. Adem&#xe1;s, se recopilaron datos demogr&#xe1;ficos, antecedentes neurol&#xf3;gicos y psiqui&#xe1;tricos, y se utilizaron escalas para evaluar s&#xed;ntomas neuropsiqui&#xe1;tricos. Resultados: de las 214 ENC, 54.21 % resultaron normales, mientras que las restantes mostraron diversos grados de deterioro cognitivo. No se encontraron diferencias estad&#xed;sticamente significativas en la presencia de depresi&#xf3;n o ansiedad entre los grupos con ENC normal y patol&#xf3;gica. Sin embargo, el 84 % de los casos present&#xf3; s&#xed;ntomas neuropsiqui&#xe1;tricos seg&#xfa;n informes de familiares, siendo la depresi&#xf3;n y la ansiedad los m&#xe1;s reportados. Conclusiones: en m&#xe1;s de la mitad de la muestra se obtuvo un rendimiento cognitivo normal y en el resto alg&#xfa;n grado de deterioro cognitivo. Se detect&#xf3; una alta frecuencia de s&#xed;ntomas neuropsiqui&#xe1;tricos. Se subraya la importancia de una ENC completa y la detecci&#xf3;n de s&#xed;ntomas neuropsiqui&#xe1;tricos para una intervenci&#xf3;n temprana en pacientes j&#xf3;venes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Deschle</LastName><ForeName>Florencia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>M&#xe9;dica especialista en Neurolog&#xed;a y en Neuropsicolog&#xed;a cl&#xed;nica. M&#xe9;dica de planta del Complejo m&#xe9;dico Hospitalario Churruca Visca. M&#xe9;dica de planta del Centro de Neurolog&#xed;a Cognitiva Hospital Brit&#xe1;nico de Buenos Aires. Buenos Aires, Argentina. florenciadeschle@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caporale</LastName><ForeName>Sof&#xed;a</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>M&#xe9;dica especialista en Neurolog&#xed;a. Jefa de residentes del Servicio de Neurolog&#xed;a del Complejo m&#xe9;dico Hospitalario Churruca Visca. Buenos Aires, Argentina. . florenciadeschle@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno</LastName><ForeName>Mar&#xed;a Cecilia</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Licenciada en Psicolog&#xed;a especialista en Neuropsicolog&#xed;a cl&#xed;nica. . florenciadeschle@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cervino</LastName><ForeName>Cecilia Ver&#xf3;nica</ForeName><Initials>CV</Initials><AffiliationInfo><Affiliation>Doctora en Psicolog&#xed;a especialista en Neuropsicolog&#xed;a cl&#xed;nica. Psic&#xf3;loga de planta del Complejo m&#xe9;dico Hospitalario Churruca Visca. Buenos Aires, Argentina. Neuropsic&#xf3;loga de planta Instituto FLENI.. florenciadeschle@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saglio</LastName><ForeName>Mar&#xed;a Laura</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Licenciada en Psicolog&#xed;a especialista en Neuropsicolog&#xed;a cl&#xed;nica. Psic&#xf3;loga de planta del Complejo m&#xe9;dico Hospitalario Churruca Visca. Neuropsic&#xf3;loga en Instituto de Investigaciones M&#xe9;dicas Lanari. Buenos Aires, Argentina. . florenciadeschle@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Povedano</LastName><ForeName>Guillermo Pablo</ForeName><Initials>GP</Initials><AffiliationInfo><Affiliation>M&#xe9;dico especialista en Neurolog&#xed;a. Jefe del Servicio de Neurolog&#xed;a del Complejo M&#xe9;dico Hospitalario Churruca Visca. M&#xe9;dico de planta de Secci&#xf3;n Neurolog&#xed;a vascular del instituto FLENI. . florenciadeschle@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berrios</LastName><ForeName>Waleska</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>M&#xe9;dica especialista en Neurolog&#xed;a. M&#xe9;dica de planta del Complejo m&#xe9;dico Hospitalario Churruca Visca. M&#xe9;dica asociada de la Secci&#xf3;n Trastornos de Memoria y Conducta del Hospital Italiano de Buenos Aires. Buenos Aires, Argentina.. florenciadeschle@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Poblaci&#xf3;n joven con queja cognitiva: performance neuropsicol&#xf3;gica y s&#xed;ntomas neuropsiqui&#xe1;tricos.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Argentina</Country><MedlineTA>Vertex</MedlineTA><NlmUniqueID>9440528</NlmUniqueID><ISSNLinking>0327-6139</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="Y">Anxiety</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="Y">Depression</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>14</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>14</Day><Hour>12</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>14</Day><Hour>8</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40657777</ArticleId><ArticleId IdType="doi">10.53680/vertex.v36i168.833</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40511746</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>9</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Risk Factors for Stricture After Endoscopic Submucosal Dissection of Large Rectal Neoplasms.</ArticleTitle><Pagination><StartPage>1112</StartPage><EndPage>1119</EndPage><MedlinePgn>1112-1119</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003827</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Although acute adverse events after endoscopic submucosal dissection, such as perforation and bleeding, are well documented, studies on stricture are scarce.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aims to identify risk factors for rectal stricture and symptomatic stricture after endoscopic submucosal dissection and to evaluate patient outcomes in a Western tertiary cancer center.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Single-center retrospective study from a prospectively collected database of rectal endoscopic submucosal dissections.</AbstractText><AbstractText Label="SETTINGS" NlmCategory="METHODS">Reference cancer center.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Patients undergoing endoscopic submucosal dissection for rectal neoplasms from July 2010 to January 2020. Exclusion criteria included incomplete resections, referral for low anterior resection, proximal diversions (in the symptomatic group), and loss to follow-up. A specific follow-up protocol was established for patients with lesions occupying more than 90% of the rectal circumference.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Rectal strictures were classified as complete or partial.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Assessment of risk factors for stricture after rectal endoscopic submucosal dissection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 109 rectal lesions resected, 94 cases were included. Twenty patients (21.3%) developed strictures (13 complete and 7 partial stricture). Univariate analysis identified distance from the anal verge &lt;5&#x2009;cm, larger size, and circumferential mucosal defect of more than 90% as significantly associated with stricture ( p &lt; 0.05). Multivariable analysis showed that only a circumferential mucosal defect of 90% or more was significantly associated with stricture ( p &lt; 0.001). None of the patients with partial stricture were symptomatic, whereas 11 of 13 with complete stricture were symptomatic. All symptomatic patients underwent serial dilations, either with balloon or digitally, with symptom resolution occurring within 1 to 8 months (mean of 7.8 sessions of dilation procedures).</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Single-center retrospective study.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Circumferential mucosal defect of 90% or more was the only significant risk factor for stricture after extensive rectal endoscopic submucosal dissection procedures on multivariable analysis. All patients with symptomatic stricture were successfully treated with dilation sessions. See Video Abstract .</AbstractText><AbstractText Label="FACTORES DE RIESGO ASOCIADOS A ESTENOSIS TRAS LA DISECCIN SUBMUCOSA ENDOSCPICA DE NEOPLASIAS RECTALES VOLUMINOSAS" NlmCategory="UNASSIGNED">ANTECEDENTES:Si bien los eventos adversos agudos tras la disecci&#xf3;n submucosa endosc&#xf3;pica, como la perforaci&#xf3;n y el sangrado, est&#xe1;n bien documentados, los estudios sobre estenosis son escasos.OBJETIVO:Este estudio busca identificar factores de riesgo para las estenosis rectales y estenosis sintom&#xe1;ticas tras la disecci&#xf3;n submucosa endosc&#xf3;pica, y evaluar los resultados de los pacientes en un centro oncol&#xf3;gico occidental de n&#xed;vel terci&#xe1;rio.DISE&#xd1;O:Estudio retrospectivo unic&#xe9;ntrico a partir de una base de datos prospectiva de disecciones submucosas endosc&#xf3;picas rectales.CONTEXTO:Centro oncol&#xf3;gico de referencia.PACIENTES:Pacientes sometidos a disecci&#xf3;n submucosa endosc&#xf3;pica por neoplasias rectales entre julio de 2010 y enero de 2020. Los criterios de exclusi&#xf3;n fueron resecciones incompletas, derivaci&#xf3;n para resecci&#xf3;n anterior baja, derivaciones proximales (grupo sintom&#xe1;tico) y p&#xe9;rdida de seguimiento. Se estableci&#xf3; un protocolo de seguimiento espec&#xed;fico para pacientes con lesiones que ocupaban m&#xe1;s del 90% de la circunferencia rectal.INTERVENCIONES:Las estenosis rectales se clasificaron como completas o parciales.PRINCIPALES MEDIDAS DE RESULTADOS:Evaluaci&#xf3;n de los factores de riesgo para estenosis tras la disecci&#xf3;n submucosa endosc&#xf3;pica rectal.RESULTADOS:De 109 lesiones rectales resecadas, se incluyeron 94 casos. Veinte pacientes (21,3%) desarrollaron estenosis (trece estenosis completas y siete estenosis parciales). El an&#xe1;lisis univariado identific&#xf3; a la distancia del margen anal &lt; 5&#x2009;cm, el mayor tama&#xf1;o y el defecto mucoso circunferencial &gt; 90% como significativamente asociados con la estenosis (p &lt; 0,05). El an&#xe1;lisis multivariante mostr&#xf3; que solo el defecto mucoso circunferencial &#x2265; 90% se asoci&#xf3; significativamente con la estenosis (p &lt; 0,001). Ninguno de los pacientes con estenosis parciales present&#xf3; s&#xed;ntomas, mientras que once de los trece con estenosis completa s&#xed; los presentaron. Todos los pacientes sintom&#xe1;ticos se sometieron a dilataciones seriadas, ya sea con bal&#xf3;n o digitales, con resoluci&#xf3;n de los s&#xed;ntomas en un plazo de 1 a 8 meses (media de 7,8 sesiones de dilataci&#xf3;n).LIMITACIONES:Estudio retrospectivo unic&#xe9;ntrico.CONCLUSIONES:Un defecto mucoso circunferencial &#x2265;90% fue el &#xfa;nico factor de riesgo significativo de estenosis tras procedimientos rectales de disecci&#xf3;n endosc&#xf3;pica submucosa extensas en el an&#xe1;lisis multivariable. Todos los pacientes con estenosis sintom&#xe1;tica fueron tratados con &#xe9;xito mediante sesiones de dilataci&#xf3;n. (Traducci&#xf3;n-Dr Osvaldo Gauto ).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2025.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rezende</LastName><ForeName>Daniel Tavares</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Division of Endoscopy, Instituto do C&#xe2;ncer do Estado de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawaguti</LastName><ForeName>Fabio S</ForeName><Initials>FS</Initials><AffiliationInfo><Affiliation>Division of Endoscopy, Instituto do C&#xe2;ncer do Estado de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Endoscopy Unit, Hospital S&#xed;rio Liban&#xea;s, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimura</LastName><ForeName>Cintia M S</ForeName><Initials>CMS</Initials><AffiliationInfo><Affiliation>Division of Gastrointestinal Surgery, Instituto do C&#xe2;ncer do Estado de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nahas</LastName><ForeName>Caio S R</ForeName><Initials>CSR</Initials><AffiliationInfo><Affiliation>Division of Gastrointestinal Surgery, Instituto do C&#xe2;ncer do Estado de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto</LastName><ForeName>Rodrigo A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Division of Gastrointestinal Surgery, Instituto do C&#xe2;ncer do Estado de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Safatle-Ribeiro</LastName><ForeName>Adriana V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Division of Endoscopy, Instituto do C&#xe2;ncer do Estado de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maluf-Filho</LastName><ForeName>Fauze</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-8875-420</Identifier><AffiliationInfo><Affiliation>Division of Endoscopy, Instituto do C&#xe2;ncer do Estado de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Ulysses</ForeName><Initials>U</Initials><Suffix>Jr</Suffix><Identifier Source="ORCID">0000-0003-1711-7347</Identifier><AffiliationInfo><Affiliation>Division of Gastrointestinal Surgery, Instituto do C&#xe2;ncer do Estado de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nahas</LastName><ForeName>Sergio C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Division of Gastrointestinal Surgery, Instituto do C&#xe2;ncer do Estado de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marques</LastName><ForeName>Carlos F S</ForeName><Initials>CFS</Initials><AffiliationInfo><Affiliation>Division of Gastrointestinal Surgery, Instituto do C&#xe2;ncer do Estado de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012004" MajorTopicYN="Y">Rectal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069916" MajorTopicYN="Y">Endoscopic Mucosal Resection</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003251" MajorTopicYN="N">Constriction, Pathologic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012007" MajorTopicYN="N">Rectum</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Early rectal cancer</Keyword><Keyword MajorTopicYN="N">Endoscopic submucosal dissection</Keyword><Keyword MajorTopicYN="N">Laterally spreading tumor</Keyword><Keyword MajorTopicYN="N">Rectal endoscopic submucosal dissection</Keyword><Keyword MajorTopicYN="N">Rectal stricture</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>31</Day><Hour>20</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>13</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>13</Day><Hour>7</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40511746</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003827</ArticleId><ArticleId IdType="pii">00003453-990000000-00976</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gorgun E, Benlice C, Abbas MA, Steele S. Experience in colon sparing surgery in North America: advanced endoscopic approaches for complex colorectal lesions. Surg Endosc. 2018;32:3114&#x2013;3121.</Citation></Reference><Reference><Citation>Kawaguti FS, Kimura CMS, Moura RN, et al. Impact of a routine colorectal endoscopic submucosal dissection in the surgical management of nonmalignant colorectal lesions treated in a referral cancer center. Dis Colon Rectum. 2023;66:e834&#x2013;e840.</Citation></Reference><Reference><Citation>Gupta N, Rodr&#xed;guez-Ruiz G, Siddiqui UD, et al. Endoscopic submucosal dissection for colorectal lesions: outcomes from a United States experience. Surg Endosc. 2022;36:236&#x2013;243.</Citation></Reference><Reference><Citation>Draganov PV, Aihara H, Karasik MS, et al. Endoscopic submucosal dissection in North America: a large prospective multicenter study. Gastroenterology. 2021;160:2317&#x2013;2327.e2.</Citation></Reference><Reference><Citation>Spadaccini M, Bourke MJ, Maselli R, et al.; ESD Western Alliance (EWA). Clinical outcome of non-curative endoscopic submucosal dissection for early colorectal cancer. Gut. 2022;71:1998&#x2013;2004.</Citation></Reference><Reference><Citation>Lee EJ, Lee JB, Choi YS, et al. Clinical risk factors for perforation during endoscopic submucosal dissection (ESD) for large-sized, nonpedunculated colorectal tumors. Surg Endosc. 2012;26:1587&#x2013;1594.</Citation></Reference><Reference><Citation>Imai K, Hotta K, Yamaguchi Y, et al. Preoperative indicators of failure of en bloc resection or perforation in colorectal endoscopic submucosal dissection: implications for lesion stratification by technical difficulties during stepwise training. Gastrointest Endosc. 2016;83:954&#x2013;962.</Citation></Reference><Reference><Citation>Kim ES, Cho KB, Park KS, et al. Factors predictive of perforation during endoscopic submucosal dissection for the treatment of colorectal tumors. Endoscopy. 2011;43:573&#x2013;578.</Citation></Reference><Reference><Citation>Mizushima T, Kato M, Iwanaga I, et al. Technical difficulty according to location, and risk factors for perforation, in endoscopic submucosal dissection of colorectal tumors. Surg Endosc. 2015;29:133&#x2013;139.</Citation></Reference><Reference><Citation>Okamoto K, Watanabe T, Komeda Y, et al. Risk factors for postoperative bleeding in endoscopic submucosal dissection of colorectal tumors. Oncology (Huntingt). 2017;93(suppl 1):35&#x2013;42.</Citation></Reference><Reference><Citation>Ogiyama H, Inoue T, Maekawa A, et al. Effect of anticoagulants on the risk of delayed bleeding after colorectal endoscopic submucosal dissection. Endosc Int Open. 2020;8:E1654&#x2013;E1663.</Citation></Reference><Reference><Citation>Yamashita K, Oka S, Tanaka S, et al. Use of anticoagulants increases risk of bleeding after colorectal endoscopic submucosal dissection. Endosc Int Open. 2018;6:E857&#x2013;E864.</Citation></Reference><Reference><Citation>Ohara Y, Toyonaga T, Tanaka S, et al. Risk of stricture after endoscopic submucosal dissection for large rectal neoplasms. Endoscopy. 2016;48:62&#x2013;70.</Citation></Reference><Reference><Citation>Hayashi T, Kudo SE, Miyachi H, et al. Management and risk factor of stenosis after endoscopic submucosal dissection for colorectal neoplasms. Gastrointest Endosc. 2017;86:358&#x2013;369.</Citation></Reference><Reference><Citation>Abe S, Sakamoto T, Takamaru H, et al. Stenosis rates after endoscopic submucosal dissection of large rectal tumors involving greater than three quarters of the luminal circumference. Surg Endosc. 2016;30:5459&#x2013;5464.</Citation></Reference><Reference><Citation>Fuccio L, Hassan C, Ponchon T, et al. Clinical outcomes after endoscopic submucosal dissection for colorectal neoplasia: a systematic review and meta-analysis. Gastrointest Endosc. 2017;86:74&#x2013;86.e17.</Citation></Reference><Reference><Citation>Saito Y, Uraoka T, Yamaguchi Y, et al. A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissections (with video). Gastrointest Endosc. 2010;72:1217&#x2013;1225.</Citation></Reference><Reference><Citation>Takeuchi Y, Iishi H, Tanaka S, et al. Factors associated with technical difficulties and adverse events of colorectal endoscopic submucosal dissection: retrospective exploratory factor analysis of a multicenter prospective cohort. Int J Colorectal Dis. 2014;29:1275&#x2013;1284.</Citation></Reference><Reference><Citation>Emmanuel A, Gulati S, Burt M, Hayee B, Haji A. Using endoscopic submucosal dissection as a routine component of the standard treatment strategy for large and complex colorectal lesions in a western tertiary referral unit. Dis Colon Rectum. 2018;61:743&#x2013;750.</Citation></Reference><Reference><Citation>Emmanuel A, Ghosh A, Lapa C, et al. Endoscopic resection of colorectal circumferential and near-circumferential laterally spreading lesions: outcomes and risk of stenosis. Int J Colorectal Dis. 2019;34:829&#x2013;836.</Citation></Reference><Reference><Citation>Kimura CMS, Kawaguti FS, Nahas CSR, et al. Long&#x2010;term outcomes of endoscopic submucosal dissection and transanal endoscopic microsurgery for the treatment of rectal tumors. J Gastroenterol Hepatol. 2021;36:1634&#x2013;1641.</Citation></Reference><Reference><Citation>Hashiguchi Y, Muro K, Saito Y, et al.; Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25:1&#x2013;42.</Citation></Reference><Reference><Citation>Luchtefeld MA, Milsom JW, Senagore A, Surrell JA, Mazier WP. Colorectal anastomotic stenosis. Results of a survey of the ASCRS membership. Dis Colon Rectum. 1989;32:733&#x2013;736.</Citation></Reference><Reference><Citation>Forshaw MJ, Maphosa G, Sankararajah D, Parker MC, Stewart M. Endoscopic alternatives in managing anastomotic strictures of the colon and rectum. Tech Coloproctol. 2006;10:21&#x2013;27.</Citation></Reference><Reference><Citation>Osera S, Ikematsu H, Odagaki T, et al. Efficacy and safety of endoscopic radial incision and cutting for benign severe anastomotic stricture after surgery for lower rectal cancer (with video). Gastrointest Endosc. 2015;81:770&#x2013;773.</Citation></Reference><Reference><Citation>Kawaguti FS, Martins BC, Nahas CSR, et al. Endoscopic radial incision and cutting procedure for a colorectal anastomotic stricture. Gastrointest Endosc. 2015;82:408&#x2013;409.</Citation></Reference><Reference><Citation>Sako T, Toyonaga T, Nakano Y, et al. Endoscopic submucosal dissection involving the anal canal presents a risk factor for postoperative stricture. Surg Endosc. 2021;35:1307&#x2013;1316.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40367000</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1678-4170</ISSN><JournalIssue CitedMedium="Internet"><Volume>122</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Arquivos brasileiros de cardiologia</Title><ISOAbbreviation>Arq Bras Cardiol</ISOAbbreviation></Journal><ArticleTitle>The Effect of Coronary Artery Bypass Graft Surgery on Contractile Function and Symptoms in Patients with Left Ventricular Dysfunction.</ArticleTitle><Pagination><StartPage>e20240486</StartPage><MedlinePgn>e20240486</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e20240486</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.36660/abc.20240486</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0066-782X2025000400304</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The degree of left ventricular (LV) dysfunction is an independent risk factor for poor outcomes in patients with chronic coronary syndrome. Coronary artery bypass graft (CABG) is the standard care for the management of ischemic heart failure to improve symptoms and prognosis. However, the predictors of improvement are still uncertain.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the effect of myocardial revascularization on LV function and symptoms in patients with CCS and reduced left ventricular ejection fraction (LVEF), as well as to identify the improvement predictors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively analyzed the data and clinical status of 136 consecutive patients with LVEF&lt;50% that underwent CABG. During clinical follow-up echocardiographic LV function was reassessed at the short-term (3.6 months) and long-term (30.8 months), and compared to baseline.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Mean pre-operative LVEF was 40.9 &#xb1; 8.6% and wall motion score index (WMSI) was 1.99 &#xb1; 0.36, both improving at long-term to 48.1 &#xb1; 15.0% (p&lt;0.001) and 1.75 &#xb1; 0.49 (p&lt;0.001), respectively. We observed that 55.7% of the patients presented an improvement of LVEF&#x2265;10% and 58.1% in WMSI &#x2265;10%. Univariate logistic regression analysis revealed that cerebrovascular disease was the only variable to be predictor of LVEF improvement. At the end of follow-up, we observed a reduction in the rate of patients in functional class III/IV when compared to baseline (65.4 vs. 10.3% - p&lt;0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patients with CCS and reduced LVEF undergoing CABG experienced improvement in both LV contractile function and size, with beneficial response in functional class.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bassan</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-0179-4661</Identifier><AffiliationInfo><Affiliation>Instituto Nacional de Cardiologia, Rio de Janeiro, RJ - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esporcatte</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Universidade do Estado do Rio de Janeiro - Doen&#xe7;as do T&#xf3;rax, Rio de Janeiro, RJ - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Correia</LastName><ForeName>Marcelo Goulart</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0002-3446-5741</Identifier></Author><Author ValidYN="Y"><LastName>Guina</LastName><ForeName>Octavio Drummond</ForeName><Initials>OD</Initials><Identifier Source="ORCID">0000-0001-6277-5985</Identifier><AffiliationInfo><Affiliation>Instituto Nacional de Cardiologia, Rio de Janeiro, RJ - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weigert</LastName><ForeName>Guilherme de Souza</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Cardiologia, Rio de Janeiro, RJ - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Gracielle Christine do Nascimento</ForeName><Initials>GCDN</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Cardiologia, Rio de Janeiro, RJ - Brasil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>por</Language><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>O Efeito da Cirurgia de Revasculariza&#xe7;&#xe3;o Mioc&#xe1;rdica na Fun&#xe7;&#xe3;o Contr&#xe1;til e Sintomas em Pacientes com Disfun&#xe7;&#xe3;o Ventricular Esquerda.</VernacularTitle></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Arq Bras Cardiol</MedlineTA><NlmUniqueID>0421031</NlmUniqueID><ISSNLinking>0066-782X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="Y">Coronary Artery Bypass</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018487" MajorTopicYN="Y">Ventricular Dysfunction, Left</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009200" MajorTopicYN="Y">Myocardial Contraction</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="por"><AbstractText Label="FUNDAMENTO" NlmCategory="OBJECTIVE">O grau de disfun&#xe7;&#xe3;o do ventr&#xed;culo esquerdo (VE) &#xe9; um fator de risco independente para piores desfechos em pacientes com s&#xed;ndrome coronariana cr&#xf4;nica (SCC). A cirurgia de revasculariza&#xe7;&#xe3;o mioc&#xe1;rdica (CRVM) &#xe9; a estrat&#xe9;gia terap&#xea;utica padr&#xe3;o na insufici&#xea;ncia card&#xed;aca isqu&#xea;mica para melhorar os sintomas e o progn&#xf3;stico. No entanto, os preditores de melhora ainda s&#xe3;o incertos.</AbstractText><AbstractText Label="OBJETIVOS" NlmCategory="OBJECTIVE">Avaliar o efeito da revasculariza&#xe7;&#xe3;o mioc&#xe1;rdica sobre a fun&#xe7;&#xe3;o do VE e sintomas em pacientes com SCC e fra&#xe7;&#xe3;o de eje&#xe7;&#xe3;o do ventr&#xed;culo esquerdo (FEVE) reduzida, e identificar os preditores de melhora.</AbstractText><AbstractText Label="M&#xc9;TODOS" NlmCategory="UNASSIGNED">Analisamos, retrospectivamente, dados e condi&#xe7;&#xe3;o cl&#xed;nica de 136 pacientes consecutivos com FEVE &lt;50%, submetidos &#xe0; CRVM. Durante o acompanhamento ecocardiogr&#xe1;fico, a fun&#xe7;&#xe3;o do VE foi reavaliada no curto (3,6 meses) e longo prazo (30,8 meses), e comparada com os dados basais.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">A FEVE m&#xe9;dia no pr&#xe9;-operat&#xf3;rio foi 40,9 &#xb1; 8,6% e a m&#xe9;dia do escore do &#xed;ndice de motilidade (WMSI) foi 1,99 &#xb1; 0,36, ambos melhorando no longo prazo para 48,1 &#xb1; 15,0% (p&lt;0,001) e 1,75 &#xb1; 0,49 (p&lt;0,001), respectivamente. Observamos que 55,7% dos pacientes apresentaram uma melhora na FEVE &#x2265;10% e 58,1% no WMSI &#x2265;10%. A an&#xe1;lise de regress&#xe3;o log&#xed;stica revelou que a doen&#xe7;a cerebrovascular foi a &#xfa;nica vari&#xe1;vel preditora de melhora na FEVE. No final do acompanhamento, observamos uma redu&#xe7;&#xe3;o na taxa de pacientes em classe funcional III/IV em compara&#xe7;&#xe3;o ao basal (65,4 vs. 10,3% - p&lt;0,001).</AbstractText><AbstractText Label="CONCLUS&#xd5;ES" NlmCategory="UNASSIGNED">Pacientes com SCC e FEVE reduzida, submetidos &#xe0; CRVM apresentaram melhora na fun&#xe7;&#xe3;o contr&#xe1;til e no tamanho do VE, com resposta ben&#xe9;fica sobre a classe funcional.</AbstractText></OtherAbstract><OtherAbstract Type="Publisher" Language="eng"><AbstractText Label="BACKGROUND">The degree of left ventricular (LV) dysfunction is an independent risk factor for poor outcomes in patients with chronic coronary syndrome. Coronary artery bypass graft (CABG) is the standard care for the management of ischemic heart failure to improve symptoms and prognosis. However, the predictors of improvement are still uncertain.</AbstractText><AbstractText Label="OBJECTIVE">To assess the effect of myocardial revascularization on LV function and symptoms in patients with CCS and reduced left ventricular ejection fraction (LVEF), as well as to identify the improvement predictors.</AbstractText><AbstractText Label="METHODS">We retrospectively analyzed the data and clinical status of 136 consecutive patients with LVEF&lt;50% that underwent CABG. During clinical follow-up echocardiographic LV function was reassessed at the short-term (3.6 months) and long-term (30.8 months), and compared to baseline.</AbstractText><AbstractText Label="RESULTS">Mean pre-operative LVEF was 40.9 &#xb1; 8.6% and wall motion score index (WMSI) was 1.99 &#xb1; 0.36, both improving at long-term to 48.1 &#xb1; 15.0% (p&lt;0.001) and 1.75 &#xb1; 0.49 (p&lt;0.001), respectively. We observed that 55.7% of the patients presented an improvement of LVEF&#x2265;10% and 58.1% in WMSI &#x2265;10%. Univariate logistic regression analysis revealed that cerebrovascular disease was the only variable to be predictor of LVEF improvement. At the end of follow-up, we observed a reduction in the rate of patients in functional class III/IV when compared to baseline (65.4 vs. 10.3% - p&lt;0.001).</AbstractText><AbstractText Label="CONCLUSIONS">Patients with CCS and reduced LVEF undergoing CABG experienced improvement in both LV contractile function and size, with beneficial response in functional class.</AbstractText></OtherAbstract><CoiStatement><b>Potencial conflito de interesse:</b> N&#xe3;o h&#xe1; conflito com o presente artigo</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>15</Day><Hour>12</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>14</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>14</Day><Hour>13</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40367000</ArticleId><ArticleId IdType="pmc">PMC12107766</ArticleId><ArticleId IdType="doi">10.36660/abc.20240486</ArticleId><ArticleId IdType="pii">S0066-782X2025000400304</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wong M, Staszewsky L, Latini R, Barlera S, Glazer R, Aknay N, et al. Severity of Left Ventricular Remodeling Defines Outcomes and Response to Therapy in Heart Failure: Valsartan Heart Failure Trial (Val-HeFT) Echocardiographic Data. J Am Coll Cardiol. 2004;43(11):2022&#x2013;2027. doi: 10.1016/j.jacc.2003.12.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2003.12.053</ArticleId><ArticleId IdType="pubmed">15172407</ArticleId></ArticleIdList></Reference><Reference><Citation>Topkara VK, Cheema FH, Kesavaramanujam S, Mercando ML, Cheema AF, Namerow PB, et al. Coronary Artery Bypass Grafting in Patients with Low Ejection Fraction. Circulation. 2005;112(9) Suppl:I344&#x2013;I350. doi: 10.1161/CIRCULATIONAHA.104.526277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.104.526277</ArticleId><ArticleId IdType="pubmed">16159844</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982&#x2013;3021. doi: 10.1016/j.jacc.2020.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.11.010</ArticleId><ArticleId IdType="pmc">PMC7755038</ArticleId><ArticleId IdType="pubmed">33309175</ArticleId></ArticleIdList></Reference><Reference><Citation>Felker GM, Shaw LK, O'Connor CM. A Standardized Definition of Ischemic Cardiomyopathy for Use in Clinical Research. J Am Coll Cardiol. 2002;39(2):210&#x2013;218. doi: 10.1016/s0735-1097(01)01738-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0735-1097(01)01738-7</ArticleId><ArticleId IdType="pubmed">11788209</ArticleId></ArticleIdList></Reference><Reference><Citation>Breathett K, Allen LA, Udelson J, Davis G, Bristow M. Changes in Left Ventricular Ejection Fraction Predict Survival and Hospitalization in Heart Failure with Reduced Ejection Fraction. Circ Heart Fail. 2016;9(10):e002962. doi: 10.1161/CIRCHEARTFAILURE.115.002962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.115.002962</ArticleId><ArticleId IdType="pmc">PMC5082710</ArticleId><ArticleId IdType="pubmed">27656000</ArticleId></ArticleIdList></Reference><Reference><Citation>Panza JA, Ellis AM, Al-Khalidi HR, Holly TA, Berman DS, Oh JK, et al. Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy. N Engl J Med. 2019;381(8):739&#x2013;748. doi: 10.1056/NEJMoa1807365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1807365</ArticleId><ArticleId IdType="pmc">PMC6814246</ArticleId><ArticleId IdType="pubmed">31433921</ArticleId></ArticleIdList></Reference><Reference><Citation>Panza JA, Holly TA, Asch FM, She L, Pellikka PA, Velazquez EJ, et al. Inducible Myocardial Ischemia and Outcomes in Patients with Coronary Artery Disease and Left Ventricular Dysfunction. J Am Coll Cardiol. 2013;61(18):1860&#x2013;1870. doi: 10.1016/j.jacc.2013.02.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.02.014</ArticleId><ArticleId IdType="pmc">PMC3755503</ArticleId><ArticleId IdType="pubmed">23500234</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third Universal Definition of Myocardial Infarction. Eur Heart J. 2012;33(20):2551&#x2013;2567. doi: 10.1093/eurheartj/ehs184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehs184</ArticleId><ArticleId IdType="pubmed">22922414</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1&#x2013;39. doi: 10.1016/j.echo.2014.10.003. e14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2014.10.003</ArticleId><ArticleId IdType="pubmed">25559473</ArticleId></ArticleIdList></Reference><Reference><Citation>Bax JJ, Schinkel AFL, Boersma E, Elhendy A, Rizzello V, Maat A, et al. Extensive Left Ventricular Remodeling does Not Allow Viable Myocardium to Improve in Left Ventricular Ejection Fraction after Revascularization and is Associated with Worse Long-Term Prognosis. Circulation. 2004;110(11) Suppl 1:II18&#x2013;II22. doi: 10.1161/01.CIR.0000138195.33452.b0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000138195.33452.b0</ArticleId><ArticleId IdType="pubmed">15364832</ArticleId></ArticleIdList></Reference><Reference><Citation>Bax JJ, Maddahi J, Poldermans D, Elhendy A, Schinkel A, Boersma E, et al. Preoperative Comparison of Different Noninvasive Strategies for Predicting Improvement in Left Ventricular Function after Coronary Artery Bypass Grafting. Am J Cardiol. 2003;92(1):1&#x2013;4. doi: 10.1016/s0002-9149(03)00454-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0002-9149(03)00454-5</ArticleId><ArticleId IdType="pubmed">12842235</ArticleId></ArticleIdList></Reference><Reference><Citation>Carluccio E, Biagioli P, Alunni G, Murrone A, Giombolini C, Ragni T, et al. Patients with Hibernating Myocardium Show Altered Left Ventricular Volumes and Shape, Which Revert after Revascularization: Evidence that Dyssynergy Might Directly Induce Cardiac Remodeling. J Am Coll Cardiol. 2006;47(5):969&#x2013;977. doi: 10.1016/j.jacc.2005.09.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2005.09.064</ArticleId><ArticleId IdType="pubmed">16516079</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Borah BJ, Cheng S, Li S, Zheng Z, Gu X, et al. Diabetes Associated with Greater Ejection Fraction Improvement after Revascularization in Patients with Reduced Ejection Fraction. 751474Front Cardiovasc Med. 2021;8 doi: 10.3389/fcvm.2021.751474.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.751474</ArticleId><ArticleId IdType="pmc">PMC8502963</ArticleId><ArticleId IdType="pubmed">34646874</ArticleId></ArticleIdList></Reference><Reference><Citation>Velagaleti RS, Vetter J, Parker R, Kurgansky KE, Sun YV, Djousse L, et al. Change in Left Ventricular Ejection Fraction with Coronary Artery Revascularization and Subsequent Risk for Adverse Cardiovascular Outcomes. Circ Cardiovasc Interv. 2022;15(4):e011284. doi: 10.1161/CIRCINTERVENTIONS.121.011284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.121.011284</ArticleId><ArticleId IdType="pmc">PMC10103079</ArticleId><ArticleId IdType="pubmed">35411780</ArticleId></ArticleIdList></Reference><Reference><Citation>Metra M, Nodari S, Parrinello G, Giubbini R, Manca C, Dei Cas L. Marked Improvement in Left Ventricular Ejection Fraction During Long-Term Beta-Blockade in Patients with Chronic Heart Failure: Clinical Correlates and Prognostic Significance. Am Heart J. 2003;145(2):292&#x2013;299. doi: 10.1067/mhj.2003.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mhj.2003.105</ArticleId><ArticleId IdType="pubmed">12595847</ArticleId></ArticleIdList></Reference><Reference><Citation>Khattar RS, Senior R, Soman P, van der Does R, Lahiri A. Regression of Left Ventricular Remodeling in Chronic Heart Failure: Comparative and Combined Effects of Captopril and Carvedilol. Am Heart J. 2001;142(4):704&#x2013;713. doi: 10.1067/mhj.2001.116768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mhj.2001.116768</ArticleId><ArticleId IdType="pubmed">11579363</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozonschi L, Kohmoto T, Osaki S, Oliveira NC, Dhingra R, Akhter SA, et al. Coronary Bypass in Left Ventricular Dysfunction and Differential Cardiac Recovery. Asian Cardiovasc Thorac Ann. 2017;25(9):586&#x2013;593. doi: 10.1177/0218492317744472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0218492317744472</ArticleId><ArticleId IdType="pubmed">29153000</ArticleId></ArticleIdList></Reference><Reference><Citation>Byty&#xe7;i I, Shenouda R, Wester P, Henein MY. Carotid Atherosclerosis in Predicting Coronary Artery Disease: A Systematic Review and Meta-Analysis. Arterioscler Thromb Vasc Biol. 2021;41(4):e224&#x2013;e237. doi: 10.1161/ATVBAHA.120.315747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.315747</ArticleId><ArticleId IdType="pubmed">33626907</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallikazaros I, Tsioufis C, Sideris S, Stefanadis C, Toutouzas P. Carotid Artery Disease as a Marker for the Presence of Severe Coronary Artery Disease in Patients Evaluated for Chest Pain. Stroke. 1999;30(5):1002&#x2013;1007. doi: 10.1161/01.str.30.5.1002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.str.30.5.1002</ArticleId><ArticleId IdType="pubmed">10229735</ArticleId></ArticleIdList></Reference><Reference><Citation>Serruys PW, Morice M-C, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. N Engl J Med. 2009;360(10):961&#x2013;972. doi: 10.1056/NEJMoa0804626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0804626</ArticleId><ArticleId IdType="pubmed">19228612</ArticleId></ArticleIdList></Reference><Reference><Citation>Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, et al. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. N Engl J Med. 2016;374(16):1511&#x2013;1520. doi: 10.1056/NEJMoa1602001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1602001</ArticleId><ArticleId IdType="pmc">PMC4938005</ArticleId><ArticleId IdType="pubmed">27040723</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z, Zhuang X, Liu M, Jian B, Fu G, Liao X, et al. Left Ventricular Volume Change and Long-Term Outcomes in Ischaemic Cardiomyopathy with or without Surgical Revascularisation: A Post-Hoc Analysis of a Randomised Controlled Trial. 101626EClinicalMedicine. 2022;53 doi: 10.1016/j.eclinm.2022.101626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101626</ArticleId><ArticleId IdType="pmc">PMC9433601</ArticleId><ArticleId IdType="pubmed">36060518</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40300259</PMID><DateRevised><Year>2025</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-1275</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>11</Issue><PubDate><Year>2025</Year><Month>Apr</Month><Day>28</Day></PubDate></JournalIssue><Title>Atencion primaria</Title><ISOAbbreviation>Aten Primaria</ISOAbbreviation></Journal><ArticleTitle>[Documentation of signs and symptoms in patients with rheumatoid arthritis: A descriptive analysis of primary care records].</ArticleTitle><Pagination><StartPage>103286</StartPage><MedlinePgn>103286</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.aprim.2025.103286</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0212-6567(25)00072-1</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vega-Morales</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Reumatolog&#xed;a y Centro de Infusi&#xf3;n, Hospital General de Zona No. 17, IMSS, Nuevo Le&#xf3;n, Mexico. Electronic address: drdavidvega@yahoo.com.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas-&#xc1;vila</LastName><ForeName>Mitzi Elena</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Reumatolog&#xed;a y Centro de Infusi&#xf3;n, Hospital General de Zona No. 17, IMSS, Nuevo Le&#xf3;n, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montoya-Montes</LastName><ForeName>Alondra Elizabeth</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Reumatolog&#xed;a y Centro de Infusi&#xf3;n, Hospital General de Zona No. 17, IMSS, Nuevo Le&#xf3;n, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gil-Flores</LastName><ForeName>Lourdes</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Reumatolog&#xed;a y Centro de Infusi&#xf3;n, Hospital General de Zona No. 17, IMSS, Nuevo Le&#xf3;n, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Documentaci&#xf3;n de signos y s&#xed;ntomas en pacientes con artritis reumatoide: an&#xe1;lisis descriptivo de las notas de primer nivel de atenci&#xf3;n.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Aten Primaria</MedlineTA><NlmUniqueID>9111075</NlmUniqueID><ISSNLinking>0212-6567</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>30</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>30</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>29</Day><Hour>18</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40300259</ArticleId><ArticleId IdType="doi">10.1016/j.aprim.2025.103286</ArticleId><ArticleId IdType="pii">S0212-6567(25)00072-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40253630</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2448-9190</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Mar</Month><Day>30</Day></PubDate></JournalIssue><Title>Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)</Title><ISOAbbreviation>Rev Alerg Mex</ISOAbbreviation></Journal><ArticleTitle>[Frequency of signs and symptoms in the Post-COVID Syndrome of subjects partially or fully recovered from COVID-19].</ArticleTitle><Pagination><StartPage>8</StartPage><EndPage>13</EndPage><MedlinePgn>8-13</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.29262/ram.v72i1.1388</ELocationID><Abstract><AbstractText Label="OBJETIVES" NlmCategory="OBJECTIVE">To evaluate the persistent symptoms in subjects with infection of COVID-19, partially or fully recovered.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">An observational, descriptive, cross-sectional, prospective study was conducted in individuals who were infected with SARS-CoV-2. We included Individuals of any gender and age who voluntarily answer a survey after developing infection to identify signs and symptoms associated, we analyzed whether there was any relationship between female sex and obesity, or age related with post-COVID-19 syndrome by X<sup>2</sup> test and t Student test.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">197 individuals were included with mean age 41.57 (SD 14.2 years), 61.9% were female. Post-COVID syndrome was present in 52.3%, depression, anosmia, dysgeusia, nausea, alopecia and behavior disorders were greater in women; arthralgia, dyspnea, cough, and odynophagia were greater in obesity being statistically significant (p&lt;0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Post-COVID syndrome was found in 52.3%, with a variety of symptoms female sex had a higher risk of presenting post-Covid syndrome with symptoms such as depression, behavior disorders, anosmia, and baldness.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rojo-Guti&#xe9;rrez</LastName><ForeName>Mar&#xed;a Isabel</ForeName><Initials>MI</Initials><Identifier Source="ORCID">0000-0003-4562-4477</Identifier><AffiliationInfo><Affiliation>Presidenta del Consejo Nacional de Inmunolog&#xed;a y Alergia, Ciudad de M&#xe9;xico.razoblanco.dulce@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moncayo-Coello</LastName><ForeName>Carol Vivian</ForeName><Initials>CV</Initials><Identifier Source="ORCID">0000-0001-7517-3991</Identifier><AffiliationInfo><Affiliation>Servicio de Alergia e inmunolog&#xed;a, Hospital Ju&#xe1;rez de M&#xe9;xico, Ciudad de M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez S&#xe1;nchez</LastName><ForeName>Ver&#xf3;nica</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-9732-2265</Identifier><AffiliationInfo><Affiliation>Divisi&#xf3;n de Investigaci&#xf3;n, Hospital Ju&#xe1;rez de M&#xe9;xico, Ciudad de M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ballesteros-Gonz&#xe1;lez</LastName><ForeName>Diego</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-9364-6411</Identifier><AffiliationInfo><Affiliation>Servicio de Alergia e inmunolog&#xed;a, Hospital Ju&#xe1;rez de M&#xe9;xico, Ciudad de M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Razo Blanco-Hern&#xe1;ndez</LastName><ForeName>Dulce Milagros</ForeName><Initials>DM</Initials><Identifier Source="ORCID">0000-0003-3869-344X</Identifier><AffiliationInfo><Affiliation>Divisi&#xf3;n de Investigaci&#xf3;n, Hospital Ju&#xe1;rez de M&#xe9;xico, Ciudad de M&#xe9;xico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType></PublicationTypeList><VernacularTitle>Frecuencia de signos y s&#xed;ntomas por s&#xed;ndrome post-COVID en pacientes re-cuperados parcial o totalmente de COVID-19.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Rev Alerg Mex</MedlineTA><NlmUniqueID>9438824</NlmUniqueID><ISSNLinking>0002-5151</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086582" MajorTopicYN="N">Anosmia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="OBJETIVOS" NlmCategory="OBJECTIVE">Evaluar los s&#xed;ntomas persistentes de pacientes con COVID-19 parcial o completamente recuperados de la enfermedad.</AbstractText><AbstractText Label="M&#xc9;TODOS" NlmCategory="UNASSIGNED">Estudio observacional, descriptivo, transversal y prospectivo, llevado a cabo en pacientes con antecedente de infecci&#xf3;n por SARS-CoV-2, de cualquier edad y g&#xe9;nero, que voluntariamente contestaran una encuesta despu&#xe9;s de padecer la infecci&#xf3;n, con la intenci&#xf3;n de identificar los signos y s&#xed;ntomas asociados. Para evaluar si los s&#xed;ntomas se asociaban con el g&#xe9;nero femenino, obesidad o edad y el s&#xed;ndrome post-COVID se utilizaron las pruebas de X<sup>2</sup> y t de Student para muestras independientes.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">Se registraron 197 pacientes, con promedio de edad de 41.57 a&#xf1;os (DE: 14.2 a&#xf1;os), 61.9% fueron mujeres. El s&#xed;ndrome post-COVID apareci&#xf3; en el 52.3% de los casos. La depresi&#xf3;n, anosmia, disgeusia, nausea, alopecia y trastornos de la conducta fueron significativamente m&#xe1;s frecuentes en las mujeres. La artralgia, disnea, tos y odinofagia mostraron significaci&#xf3;n estad&#xed;stica en pacientes con obesidad (p &lt;0.05).</AbstractText><AbstractText Label="CONCLUSIONES" NlmCategory="CONCLUSIONS">Se calcul&#xf3; una frecuencia del 52.3% de s&#xed;ndrome post-COVID, con una variedad de signos y s&#xed;ntomas. Las mujeres tuvieron mayor riesgo de padecer el s&#xed;ndrome post-COVID, con s&#xed;ntomas como: depresi&#xf3;n, trastornos de la conducta, anosmia y alopecia.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Behavior disorders</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Obesity</Keyword><Keyword MajorTopicYN="N">Post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Los autores declaran no tener ning&#xfa;n conflicto de intereses.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>20</Day><Hour>15</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>20</Day><Hour>15</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>20</Day><Hour>10</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40253630</ArticleId><ArticleId IdType="doi">10.29262/ram.v72i1.1388</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, et al. Post-acute COVID-19 syndrome. Nature Med 2021; 27 (4): 601-615. doi: 10.1038/s41591-021-01283-z</Citation></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis 2021; 53 (10): 737-754. doi: 10.1080/23744235.2021.1924397</Citation></Reference><Reference><Citation>Afrin LB, Weinstock LB, Molderings GJ. Covid-19 hyperinflammation and post-COVID19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis 2020; 100: 327-332. doi: 10.1016/j.ijid.2020.09.016</Citation></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Cuadrado ML, et al. Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification. Int J Environ Res Public Health 2021; 18 (5): 2621. doi: 10.3390/ijerph18052621</Citation></Reference><Reference><Citation>Lechner-Scott J, Levy M, Hawkes C, Yeh A, Giovannoni G. Long COVID or post COVID-19 syndrome. Mult Scler Relat Disord 2021; 55: 103268. doi: 10.1016/j.msard.2021.103268</Citation></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Clarke JM, et al. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine 2021; 24 (36): 100899. doi: 10.1016/j.eclinm.2021.100899</Citation></Reference><Reference><Citation>Carod-Artal FJ. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved. Rev Neurol 2021; 72 (11): 384-396. doi: 10.33588/rn.7211.2021230</Citation></Reference><Reference><Citation>Montani D, Savale L, Beurnier A, Colle R, et al. Multidisciplinary approach for post-acute COVID-19 syndrome: time to break down the walls. Eur Respir J 2021; 58 (1): 2101090. doi: 10.1183/13993003.01090-2021</Citation></Reference><Reference><Citation>Malkova A, Kudryavtsev I, Starshinova A, Kudlay D, et al. Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form. Pathogens 2021; 10 (11): 1408. doi: 10.3390/pathogens10111408</Citation></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, Nair N, et al. Extrapulmonary manifestations of COVID-19. Nat Med 2020; 26 (7): 1017-1032. doi: 10.1038/s41591-020-0968-3</Citation></Reference><Reference><Citation>Cortes-Rivera M, Mastronardi C, Silva-Aldana CT, Arcos-Burgos M, et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review. Diagnostics (Basel) 2019; 9 (3): 91. doi: 10.3390/diagnostics9030091</Citation></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez JM, Andr&#xe9;s M, et al. (COVID19-ALC research group). Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect 2021; 82 (3): 378-383. doi: 10.1016/j.jinf.2021.01.004</Citation></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, Oben J, et al; COVERSCAN study investigators. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open 2021; 11 (3): e048391. doi: 10.1136/bmjopen-2020-048391</Citation></Reference><Reference><Citation>Wohleb ES, Franklin T, Iwata M, Duman RS. Integrating neuroimmune systems in the neurobiology of depression. Nat Rev Neurosci 2016; 17 (8): 497-511. doi: 10.1038/nrn.2016.69</Citation></Reference><Reference><Citation>Torales J, O'Higgins M, Castaldelli-Maia JM, Ventriglio A. The outbreak of COVID-19 coronavirus and its impact on global mental health. Int J Soc Psychiatry 2020; 66 (4): 317-320. doi: 10.1177/0020764020915212</Citation></Reference><Reference><Citation>Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav Immun 2020; 89: 531-542. doi: 10.1016/j.bbi.2020.05.048</Citation></Reference><Reference><Citation>Wong DKC, Gendeh HS, Thong HK, Lum SG, et al. A review of smell and taste dysfunction in COVID-19 patients. Med J Malaysia 2020; 75 (5): 574-581.</Citation></Reference><Reference><Citation>Izquierdo-Dom&#xed;nguez A, Rojas-Lechuga MJ, Chiesa-Estomba C, Calvo-Henr&#xed;quez C, et al. Smell and Taste Dysfunction in COVID-19 Is Associated With Younger Age in Ambulatory Settings: A Multicenter Cross-Sectional Study. J Investig Allergol Clin Immunol 2020; 30 (5): 346-357. doi: 10.18176/jiaci.0595</Citation></Reference><Reference><Citation>Brito-Zer&#xf3;n P, Conangla FL, Kostov B, Moragas MA, et al. Manifestaciones persistentes de la COVID-19. Gu&#xed;a de pr&#xe1;ctica cl&#xed;nica. 1&#xaa; ed. Barcelona: Sociedad Catalana de Medicina Familiar i Comunit&#xe0;ria (CAMFiC); 2020. p. 1-43. https://www.semfyc.es/formaciony-recursos/manifestaciones-persistentes-de-la-covid-19-guia-de-practica-clinica/.2020.</Citation></Reference><Reference><Citation>CDC, COVID-19 and Your Health, Centers for Disease Control and Prevention. Afecciones persistentes al COVID-19 y afecciones posteriors al COVID-19; 2022. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects.html.</Citation></Reference><Reference><Citation>Post COVID-19 condition: WHO supports standardization of clinical data collection and reporting (n.d.). https://www.who.int/news/item/12-08-2021-post-covid-19-condition-whosupports-standardization-of-clinical-data-collection-and-reporting.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40085057</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Persistent Sitting and Walking Difficulties After Abdominoperineal Excision and Anterior Resection: Results From the Quality of Life in Rectal Cancer Study.</ArticleTitle><Pagination><StartPage>704</StartPage><EndPage>712</EndPage><MedlinePgn>704-712</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003710</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The main surgical resection options in rectal cancer are anterior resection for tumors in the mid- or upper rectum and abdominoperineal excision for tumors in the lower rectum. A previous study showed long-term persistent perineal symptoms and sitting difficulties after abdominoperineal excision.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To examine the prevalence and extent of sitting and walking difficulties after abdominoperineal excision compared with anterior resection.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">An observational, prospective, longitudinal, multicenter, international study.</AbstractText><AbstractText Label="SETTINGS" NlmCategory="METHODS">Data were collected from participants in the quality of life in rectal cancer study. Participants answered questionnaires about bodily functions, symptoms, and quality of life at baseline and at 1 and 2 years after diagnosis.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Patients with newly diagnosed rectal cancer, regardless of stage, were included. The study included 1024 patients, of whom 64% underwent anterior resection and 36% underwent abdominoperineal excision.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">The primary objective was to estimate the prevalence and ORs of sitting or walking difficulties between the 2 surgical procedure groups: abdominoperineal excision and anterior resection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In the group of patients who underwent abdominoperineal excision, 29% had sitting difficulties after 2 years compared with 12% in the group who underwent anterior resection (OR, 2.65; 95% CI, 1.71-4.09; p &lt; 0.0001). Walking difficulties after 2 years were reported by 35% after abdominoperineal excision compared with 24% after anterior resection (OR, 1.50; 95% CI, 1.02-2.22; p = 0.04).</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">The observational nature of the study could be regarded as a limitation.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Abdominoperineal excision was associated with both sitting and walking difficulties among patients with rectal cancer at significantly higher rates compared with anterior resection. It is probable that attention from health care could improve the situation of the patients through enhanced rehabilitation. See Video Abstract .</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov (NCT01477229).</AbstractText><AbstractText Label="DIFICULTADES PERSISTENTES PARA SENTARSE Y CAMINAR POSTERIOR A LA ESCISIN ABDOMINOPERINEAL Y RESECCIN ANTERIOR RESULTADOS DEL ESTUDIO QOLIRECT" NlmCategory="UNASSIGNED">ANTECEDENTES:Las principales opciones de resecci&#xf3;n quir&#xfa;rgica en el c&#xe1;ncer de recto son la resecci&#xf3;n anterior para los tumores en el recto medio o superior y la escisi&#xf3;n abdominoperineal para los tumores en el recto inferior. Un estudio previo mostr&#xf3; s&#xed;ntomas perineales persistentes a largo plazo y dificultades para la sedestaci&#xf3;n posterior a la escisi&#xf3;n abdominoperineal.OBJETIVO:Examinar la prevalencia y el grado de dificultades para sentarse y caminar despu&#xe9;s de la escisi&#xf3;n abdominoperineal en comparaci&#xf3;n con la resecci&#xf3;n anterior.DISE&#xd1;O:Estudio observacional, prospectivo, longitudinal, multic&#xe9;ntrico e internacional.ESTABLECIMIENTOS:Se recopilaron datos de los participantes en el estudio QoLiRect. Los participantes respondieron cuestionarios sobre funciones corporales, s&#xed;ntomas y calidad de vida al inicio y tras 1 y 2 a&#xf1;os posterior al diagn&#xf3;stico.PACIENTES:Se incluyeron pacientes con c&#xe1;ncer de recto de reciente diagn&#xf3;stico independientemente del estadio. El estudio incluy&#xf3; a 1024 pacientes, de los cuales el 64 % fueron sometidos a una resecci&#xf3;n anterior y el 36 % a una escisi&#xf3;n abdominoperineal.PRINCIPALES MEDIDAS DE RESULTADOS:El objetivo principal fue estimar la prevalencia y los odds ratios (OR) de dificultades para sentarse o caminar entre los dos grupos de procedimientos quir&#xfa;rgicos: escisi&#xf3;n abdominoperineal y resecci&#xf3;n anterior.RESULTADOS:En el grupo de pacientes sometidos a la escisi&#xf3;n abdominoperineal, el 29% ten&#xed;a dificultades para sentarse tras 2 a&#xf1;os posterior a la cirug&#xed;a en comparaci&#xf3;n con el 12% en el grupo que fue sometido a resecci&#xf3;n anterior (OR 2,65, IC del 95% 1,71-4,09, p &lt; 0,0001). Las dificultades para caminar posterior a los 2 a&#xf1;os se informaron en el 35% despu&#xe9;s de la escisi&#xf3;n abdominoperineal en comparaci&#xf3;n con el 24% despu&#xe9;s de la resecci&#xf3;n anterior (OR 1,50, IC del 95% 1,02-2,22, p = 0,04).LIMITACIONES:La naturaleza observacional del estudio podr&#xed;a considerarse una limitaci&#xf3;n.CONCLUSIONES:La escisi&#xf3;n abdominoperineal se asoci&#xf3; con dificultades para sentarse y caminar en pacientes con c&#xe1;ncer rectal con tasas significativamente mayores en comparaci&#xf3;n con la resecci&#xf3;n anterior. Es probable que la atenci&#xf3;n m&#xe9;dica pueda mejorar la situaci&#xf3;n de los pacientes mediante una mejor rehabilitaci&#xf3;n. (Traducci&#xf3;n-Dr Osvaldo Gauto ).</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Colon and Rectal Surgeons.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bj&#xf6;rklund Sand</LastName><ForeName>Lina</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Surgery, SSORG-Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Region V&#xe4;stra G&#xf6;taland, Alings&#xe5;s Lasarett, Alings&#xe5;s, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larsson</LastName><ForeName>Charlotta</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgery, SSORG-Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Region V&#xe4;stra G&#xf6;taland, Sahlgrenska University Hospital/&#xd6;stra, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gr&#xf6;nkvist</LastName><ForeName>Rode</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgery, SSORG-Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haglind</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Surgery, SSORG-Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Region V&#xe4;stra G&#xf6;taland, Sahlgrenska University Hospital/&#xd6;stra, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angenete</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Surgery, SSORG-Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Region V&#xe4;stra G&#xf6;taland, Sahlgrenska University Hospital/&#xd6;stra, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01477229</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012004" MajorTopicYN="Y">Rectal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078542" MajorTopicYN="Y">Proctectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016138" MajorTopicYN="Y">Walking</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077708" MajorTopicYN="Y">Sitting Position</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010502" MajorTopicYN="N">Perineum</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Abdominoperineal excision</Keyword><Keyword MajorTopicYN="N">Anterior resection</Keyword><Keyword MajorTopicYN="N">Perineal symptoms</Keyword><Keyword MajorTopicYN="N">Rectal cancer</Keyword><Keyword MajorTopicYN="N">Sitting difficulties</Keyword><Keyword MajorTopicYN="N">Walking difficulties</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>26</Day><Hour>18</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>14</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>14</Day><Hour>11</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40085057</ArticleId><ArticleId IdType="pmc">PMC12094259</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003710</ArticleId><ArticleId IdType="pii">00003453-202506000-00012</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Minsky BD. Emerging trends in the treatment of rectal cancer. Acta Oncol. 2019;58:1343&#x2013;1351.</Citation><ArticleIdList><ArticleId IdType="pubmed">31271081</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogner A, Kirchberg J, Weitz J, Fritzmann J. State of the art&#x2014;rectal cancer surgery. Visc Med. 2019;35:252&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6738181</ArticleId><ArticleId IdType="pubmed">31602388</ArticleId></ArticleIdList></Reference><Reference><Citation>Benson AB, Venook AP, Al-Hawary MM, et al. . Rectal cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20:1139&#x2013;1167.</Citation><ArticleIdList><ArticleId IdType="pubmed">36240850</ArticleId></ArticleIdList></Reference><Reference><Citation>West NP, Anderin C, Smith KJ, Holm T, Quirke P; European Extralevator Abdominoperineal Excision Study Group. Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg. 2010;97:588&#x2013;599.</Citation><ArticleIdList><ArticleId IdType="pubmed">20186891</ArticleId></ArticleIdList></Reference><Reference><Citation>Asplund D, Haglind E, Angenete E. Outcome of extralevator abdominoperineal excision compared with standard surgery: results from a single centre. Colorectal Dis. 2012;14:1191&#x2013;1196.</Citation><ArticleIdList><ArticleId IdType="pubmed">22221401</ArticleId></ArticleIdList></Reference><Reference><Citation>Musters GD, Buskens CJ, Bemelman WA, Tanis PJ. Perineal wound healing after abdominoperineal resection for rectal cancer: a systematic review and meta-analysis. Dis Colon Rectum. 2014;57:1129&#x2013;1139.</Citation><ArticleIdList><ArticleId IdType="pubmed">25101610</ArticleId></ArticleIdList></Reference><Reference><Citation>Colov EP, Klein M, Gogenur I. Wound complications and perineal pain after extralevator versus standard abdominoperineal excision: a nationwide study. Dis Colon Rectum. 2016;59:813&#x2013;821.</Citation><ArticleIdList><ArticleId IdType="pubmed">27505109</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakonarson A, Algethami N, Lydrup ML, Buchwald P. Perineal wound healing after abdominoperineal resection for rectal cancer: a retrospective cohort study. Int J Colorectal Dis. 2022;37:1029&#x2013;1034.</Citation><ArticleIdList><ArticleId IdType="pubmed">35396618</ArticleId></ArticleIdList></Reference><Reference><Citation>Asplund D, Prytz M, Bock D, Haglind E, Angenete E. Persistent perineal morbidity is common following abdominoperineal excision for rectal cancer. Int J Colorectal Dis. 2015;30:1563&#x2013;1570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4624814</ArticleId><ArticleId IdType="pubmed">26245948</ArticleId></ArticleIdList></Reference><Reference><Citation>Feddern ML, Jensen TS, Laurberg S. Chronic pain in the pelvic area or lower extremities after rectal cancer treatment and its impact on quality of life: a population-based cross-sectional study. Pain. 2015;156:1765&#x2013;1771.</Citation><ArticleIdList><ArticleId IdType="pubmed">26010459</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiltink LM, Chen TY, Nout RA, et al. . Health-related quality of life 14 years after preoperative short-term radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomised trial. Eur J Cancer. 2014;50:2390&#x2013;2398.</Citation><ArticleIdList><ArticleId IdType="pubmed">25060825</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayers AE, Patel RK, Hunter IA. Perineal hernia formation following extralevator abdominoperineal excision. Colorectal Dis. 2015;17:351&#x2013;355.</Citation><ArticleIdList><ArticleId IdType="pubmed">25413255</ArticleId></ArticleIdList></Reference><Reference><Citation>Asplund D, Heath J, Gonzalez E, et al. . Self-reported quality of life and functional outcome in patients with rectal cancer&#x2014;QoLiRECT. Dan Med J. 2014;61:A4841.</Citation><ArticleIdList><ArticleId IdType="pubmed">24814743</ArticleId></ArticleIdList></Reference><Reference><Citation>Fava GA, Tomba E, Sonino N. Clinimetrics: the science of clinical measurements. Int J Clin Pract. 2012;66:11&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">22171900</ArticleId></ArticleIdList></Reference><Reference><Citation>Ara T. Brunnermunzel.
https://cran.r-project.org/web/packages/brunnermunzel/brunnermunzel.pdf. Accessed December 21, 2024.</Citation></Reference><Reference><Citation>Mortensen AR, Thyo A, Emmertsen KJ, Laurberg S. Chronic pain after rectal cancer surgery&#x2014;development and validation of a scoring system. Colorectal Dis. 2019;21:90&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">30269401</ArticleId></ArticleIdList></Reference><Reference><Citation>Kvalitetsregister. Kunskapsbanken.
https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/kvalitetsregister/. Accessed December 21, 2024.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>